October 2017
M T W T F S S
« Sep    
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Archives

Please support our Sponsors

Short Term Treatment Versus Long Term Management of Neck and Back Disability in Older Adults Utilizing Spinal Manipulative Therapy and Supervised Exercise

Chiro.Org Blog: Self-report questionnaires administered at 2 baseline visits and 4, 12, 24, 36, 52, and 78 weeks post-randomization. Primary outcomes include back and neck disability, measured by the Oswestry Disability Index and Neck Disability Index. Secondary outcomes include pain, general health status, improvement, self-efficacy, kinesiophobia, satisfaction, and medication use. Functional outcome assessment occurs at baseline and week 37 for hand grip strength, short physical performance battery, and accelerometry. Individual qualitative interviews are conducted when treatment ends. Data on expectations, falls, side effects, and adverse events are systematically collected. […]

Workers’ Compensation, Return to Work, and Lumbar Fusion for Spondylolisthesis

Chiro.Org Blog: This is an interesting follow-up to a 2011 study drawn from the Ohio Bureau of Workers’ Compensation database. [Startling New Study Reveals That Back Surgery Fails 74% of the Time] In the 2011 study, two years AFTER surgery, only 26 percent had returned to work. That translates to a resounding 74% failure rate! In this current study, researchers reviewed the files of 686 workers who underwent fusion surgery for spondylolisthesis between 1993 and 2013, revealing that only 29.9% of them ever returned to work (for at least 6 months). The failure rate (meaning return-to-work) was 70.1%. […]

Cost Analysis Related to Dose-response of Spinal Manipulative Therapy for Chronic Low Back Pain

Chiro.Org Blog: This study shows that manipulation can have a modicum of benefit in LBP-related pain and disability without significantly increasing treatment or societal costs. In the main results paper reporting pain and disability on 100-point scales, Haas et al found an 8.6-point advantage in pain (p=.002) and 7.5-point advantage in disability (p=.011) for SMT 12 compared to the control at 12 weeks. In this study, we found that this benefit may occur without significant increases in costs of treatment or lost productivity. […]